FENNEX Ltd

We are moving ahead, never looking back, helping clients enhance the in-venue live fan experience one win at a time. With over 2000 live in-venue events Fannex has become a North American leader in creating and enhancing fan experiences. Paulo Douglas is the lead full-stack developer, responsible for both front-end and back-end development and infrastrcture scaling strategies. Adam Leslie focuses on new marketing initiatives and is a support to the business develop team. Lucas Radawetz is a big sports enthusiast and gamer and joins us as a Red River College Polytechnic (RRCP) graduate in Business Admin and Marketing. Experience: 7+ years of experience in DevOps Technologies. Use our industry leading activation control to create, control, and measure engaging experiences. Telling a story using data as the action occurs is an essential consideration for any producer.

Fennec Pharmaceuticals is a biotechnology company dedicated to improving the lives of children with cancer who experience hearing loss as a result of chemotherapy.

We deliver a win for our clients and a win for the environment. At Fēnix Energy, we envision a better way to deliver energy. This allows us to develop Thermal Energy Assets that deliver a win for the environment and a win for the bottom line. Founded in 2010, Fēnix Energy has built a reputation on delivering projects that are business-case driven. Using a combination of built-environment expertise and industry leading technology, we ensure that property owners and developers benefit from additional revenue and increased property values, while also supporting the growth of sustainable cities across North America. Through our Design, Build, Own, Operate approach, Fēnix Energy delivers an unparalleled level of expertise in the arenas of asset creation, district energy, building-integrated mechanical infrastructure, and utility design. And we do it through our Design, Build, Own, Operate development model.

Welcome to Fennech Financial, the next-generation Corporate Banking Platform as a Service that aims at hyper-automating Payments, Liquidity Management, working capital and more broadly Treasury and Finance. At Fennech, we understand the unique challenges enterprises face in navigating today’s complex financial landscape. At Fennech, we leverage cutting-edge artificial intelligence and machine learning to empower businesses with seamless financial management solutions. Fennech’s IP derives from its’ smart architectural combination of core components delivered as a Platform-As-A-Service (PaaS). We selected Fennech to deliver our 2 major banking API and FX hub infrastructures because we were impressed by both the flexibility, capability, and power of the Fennech platform, and the experience and expertise of the team. In Fennech we saw a Platform and a Senior Management Team that was offering a new innovative service that could help London further build on its reputation for being the home of the most exciting new FinTechs. Mitratech have partnered with Fennech to provide our clients with the options to find, risk assess, manage and decommission their Shadow IT applications across their life cycle whether EUCs, Models or Excel files. Working in partnership with Fennech meant that we are able to quickly, and cost-effectively, add significant new functionality to our electronic accounting and cash management solutions for our Insurance and Reinsurance customers.

A qualified engineer and lifetime entrepreneur, Fenwick has dedicated 20+ years leading technology businesses and deploying innovative processes. Not only does this improve efficiency, but it provides invaluable data insight that will inform positive change at every level.

Cenofex Innovations is poised to make a significant impact in the treatment of lymphoedema. With its novel technology, Cenofex aims to provide an accessible, scalable, and convenient solution for the millions of patients who suffer from this debilitating condition. Cenofex Founders Drs Gho and Weaver were the inaugural NSW Health Rosenman Institute Scholars, awarded a two-year fellowship at the institute, housed within UCSF (2015-17). Cenofex Innovations was awarded a $10,000 prize to undertake IP work with DCC. Cenofex Innovations was awarded a $10,000 prize to develop a regulatory strategy with Brandwood. Cenofex Innovations was awarded $1.5M from the NSW MDF in 2018. Cenofex CEO Dr Gho and Lead Engineer Dr Richards were awarded REDI placement fellowships in 2021 and 2022 respectively. Cenofex Innovations is deeply grateful to NSW Health for the invaluable support provided through the Medical Device Fund (MDF).